Global Biosimilar Drug Market Professional Survey Report 2016
This report
Mainly covers the following product types
The segment applications including
Segment regions including (the separated region report can also be offered)
Data including (both global and regions): Market Size (both volume - K Dose and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
Mainly covers the following product types
The segment applications including
Segment regions including (the separated region report can also be offered)
- USA
- China
- Europe
- Japan
- Hospira
- Sandoz
- Teva Pharmaceutical Industries
- Pfizer
- Merck Sharp & Dohme
- Celltrion
- Amgen
- Biogen
- Mylan
- Biocon
- Dr. Reddy’s Laboratories
- Boehringer Ingelheim GmbH
- Intas Pharmaceuticals
- LG Life Sciences
- Emcure Pharmaceuticals
- Probiomed
- Biosidus
- 3SBio
- WOCKHARDT
- Sun Pharmaceutical Industries
- Shanghai Fosun Pharmaceutical
- Qilu Pharmaceutical
- Allergan
- Dongbao
- Samsung Biologics
- Zydus Cadila.
- Dong-A Pharmaceutical
Data including (both global and regions): Market Size (both volume - K Dose and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 INDUSTRY OVERVIEW OF BIOSIMILAR DRUG
1.1 Definition and Specifications of Biosimilar Drug
1.1.1 Definition of Biosimilar Drug
1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.3 Applications of Biosimilar Drug
1.4 Industry Chain Structure of Biosimilar Drug
1.5 Industry Overview and Major Regions Status of Biosimilar Drug
1.5.1 Industry Overview of Biosimilar Drug
1.5.2 Global Major Regions Status of Biosimilar Drug
1.6 Industry Policy Analysis of Biosimilar Drug
1.7 Industry News Analysis of Biosimilar Drug
2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOSIMILAR DRUG
2.1 Raw Material Suppliers and Price Analysis of Biosimilar Drug
2.2 Equipment Suppliers and Price Analysis of Biosimilar Drug
2.3 Labor Cost Analysis of Biosimilar Drug
2.4 Other Costs Analysis of Biosimilar Drug
2.5 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.6 Manufacturing Process Analysis of Biosimilar Drug
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOSIMILAR DRUG
3.1 Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2015
4 GLOBAL BIOSIMILAR DRUG OVERALL MARKET OVERVIEW
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Biosimilar Drug Capacity and Growth Rate Analysis
4.2.2 2015 Biosimilar Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Biosimilar Drug Sales and Growth Rate Analysis
4.3.2 2015 Biosimilar Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Biosimilar Drug Sales Price
4.4.2 2015 Biosimilar Drug Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Biosimilar Drug Gross Margin
4.5.2 2015 Biosimilar Drug Gross Margin Analysis (Company Segment)
5 BIOSIMILAR DRUG REGIONAL MARKET ANALYSIS
5.1 USA Biosimilar Drug Market Analysis
5.1.1 USA Biosimilar Drug Market Overview
5.1.2 USA 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Biosimilar Drug Sales Price Analysis
5.1.4 USA 2015 Biosimilar Drug Market Share Analysis
5.2 China Biosimilar Drug Market Analysis
5.2.1 China Biosimilar Drug Market Overview
5.2.2 China 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Biosimilar Drug Sales Price Analysis
5.2.4 China 2015 Biosimilar Drug Market Share Analysis
5.3 Europe Biosimilar Drug Market Analysis
5.3.1 Europe Biosimilar Drug Market Overview
5.3.2 Europe 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Biosimilar Drug Sales Price Analysis
5.3.4 Europe 2015 Biosimilar Drug Market Share Analysis
5.4 Japan Biosimilar Drug Market Analysis
5.4.1 Japan Biosimilar Drug Market Overview
5.4.2 Japan 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2011-2016E Biosimilar Drug Sales Price Analysis
5.4.4 Japan 2015 Biosimilar Drug Market Share Analysis
6 GLOBAL 2011-2016E BIOSIMILAR DRUG SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2011-2016E Biosimilar Drug Sales by Type
6.2 Different Types Biosimilar Drug Product Interview Price Analysis
6.3 Different Types Biosimilar Drug Product Driving Factors Analysis
7 GLOBAL 2011-2016E BIOSIMILAR DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF BIOSIMILAR DRUG
8.1 Hospira
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Hospira 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Hospira 2015 Biosimilar Drug Business Region Distribution Analysis
8.2 Sandoz
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Sandoz 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sandoz 2015 Biosimilar Drug Business Region Distribution Analysis
8.3 Teva Pharmaceutical Industries
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Teva Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Teva Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Pfizer 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2015 Biosimilar Drug Business Region Distribution Analysis
8.5 Merck Sharp & Dohme
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck Sharp & Dohme 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck Sharp & Dohme 2015 Biosimilar Drug Business Region Distribution Analysis
8.6 Celltrion
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Celltrion 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celltrion 2015 Biosimilar Drug Business Region Distribution Analysis
8.7 Amgen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Amgen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amgen 2015 Biosimilar Drug Business Region Distribution Analysis
8.8 Biogen
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Biogen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Biogen 2015 Biosimilar Drug Business Region Distribution Analysis
8.9 Mylan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Mylan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Mylan 2015 Biosimilar Drug Business Region Distribution Analysis
8.10 Biocon
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Biocon 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Biocon 2015 Biosimilar Drug Business Region Distribution Analysis
8.11 Dr. Reddy’s Laboratories
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Business Region Distribution Analysis
8.12 Boehringer Ingelheim GmbH
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Business Region Distribution Analysis
8.13 Intas Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Intas Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Intas Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.14 LG Life Sciences
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 LG Life Sciences 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 LG Life Sciences 2015 Biosimilar Drug Business Region Distribution Analysis
8.15 Emcure Pharmaceuticals
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Emcure Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Emcure Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.16 Probiomed
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Probiomed 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Probiomed 2015 Biosimilar Drug Business Region Distribution Analysis
8.17 Biosidus
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Biosidus 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Biosidus 2015 Biosimilar Drug Business Region Distribution Analysis
8.18 3SBio
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 3SBio 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 3SBio 2015 Biosimilar Drug Business Region Distribution Analysis
8.19 WOCKHARDT
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 WOCKHARDT 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 WOCKHARDT 2015 Biosimilar Drug Business Region Distribution Analysis
8.20 Sun Pharmaceutical Industries
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Sun Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Sun Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.21 Shanghai Fosun Pharmaceutical
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.22 Qilu Pharmaceutical
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 Qilu Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 Qilu Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.23 Allergan
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Allergan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Allergan 2015 Biosimilar Drug Business Region Distribution Analysis
8.24 Dongbao
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Dongbao 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Dongbao 2015 Biosimilar Drug Business Region Distribution Analysis
8.25 Samsung Biologics
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.3 Samsung Biologics 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.25.4 Samsung Biologics 2015 Biosimilar Drug Business Region Distribution Analysis
8.26 Zydus Cadila.
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.3 Zydus Cadila. 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.26.4 Zydus Cadila. 2015 Biosimilar Drug Business Region Distribution Analysis
8.27 Dong-A Pharmaceutical
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.3 Dong-A Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.27.4 Dong-A Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
9 DEVELOPMENT TREND OF ANALYSIS OF MARKET
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Biosimilar Drug Consumption Forecast
9.2.2 China 2016-2021 Biosimilar Drug Consumption Forecast
9.2.3 Europe 2016-2021 Biosimilar Drug Consumption Forecast
9.2.4 Japan 2016-2021 Biosimilar Drug Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 BIOSIMILAR DRUG MARKETING MODEL ANALYSIS
10.1 Biosimilar Drug Regional Marketing Model Analysis
10.2 Biosimilar Drug International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Biosimilar Drug by Regions
10.4 Biosimilar Drug Supply Chain Analysis
11 CONSUMERS ANALYSIS OF BIOSIMILAR DRUG
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF BIOSIMILAR DRUG
12.1 New Project SWOT Analysis of Biosimilar Drug
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug
13 CONCLUSION OF THE GLOBAL BIOSIMILAR DRUG MARKET PROFESSIONAL SURVEY REPORT 2016
1.1 Definition and Specifications of Biosimilar Drug
1.1.1 Definition of Biosimilar Drug
1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.3 Applications of Biosimilar Drug
1.4 Industry Chain Structure of Biosimilar Drug
1.5 Industry Overview and Major Regions Status of Biosimilar Drug
1.5.1 Industry Overview of Biosimilar Drug
1.5.2 Global Major Regions Status of Biosimilar Drug
1.6 Industry Policy Analysis of Biosimilar Drug
1.7 Industry News Analysis of Biosimilar Drug
2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOSIMILAR DRUG
2.1 Raw Material Suppliers and Price Analysis of Biosimilar Drug
2.2 Equipment Suppliers and Price Analysis of Biosimilar Drug
2.3 Labor Cost Analysis of Biosimilar Drug
2.4 Other Costs Analysis of Biosimilar Drug
2.5 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.6 Manufacturing Process Analysis of Biosimilar Drug
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOSIMILAR DRUG
3.1 Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2015
4 GLOBAL BIOSIMILAR DRUG OVERALL MARKET OVERVIEW
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Biosimilar Drug Capacity and Growth Rate Analysis
4.2.2 2015 Biosimilar Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Biosimilar Drug Sales and Growth Rate Analysis
4.3.2 2015 Biosimilar Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Biosimilar Drug Sales Price
4.4.2 2015 Biosimilar Drug Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Biosimilar Drug Gross Margin
4.5.2 2015 Biosimilar Drug Gross Margin Analysis (Company Segment)
5 BIOSIMILAR DRUG REGIONAL MARKET ANALYSIS
5.1 USA Biosimilar Drug Market Analysis
5.1.1 USA Biosimilar Drug Market Overview
5.1.2 USA 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Biosimilar Drug Sales Price Analysis
5.1.4 USA 2015 Biosimilar Drug Market Share Analysis
5.2 China Biosimilar Drug Market Analysis
5.2.1 China Biosimilar Drug Market Overview
5.2.2 China 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Biosimilar Drug Sales Price Analysis
5.2.4 China 2015 Biosimilar Drug Market Share Analysis
5.3 Europe Biosimilar Drug Market Analysis
5.3.1 Europe Biosimilar Drug Market Overview
5.3.2 Europe 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Biosimilar Drug Sales Price Analysis
5.3.4 Europe 2015 Biosimilar Drug Market Share Analysis
5.4 Japan Biosimilar Drug Market Analysis
5.4.1 Japan Biosimilar Drug Market Overview
5.4.2 Japan 2011-2016E Biosimilar Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2011-2016E Biosimilar Drug Sales Price Analysis
5.4.4 Japan 2015 Biosimilar Drug Market Share Analysis
6 GLOBAL 2011-2016E BIOSIMILAR DRUG SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2011-2016E Biosimilar Drug Sales by Type
6.2 Different Types Biosimilar Drug Product Interview Price Analysis
6.3 Different Types Biosimilar Drug Product Driving Factors Analysis
7 GLOBAL 2011-2016E BIOSIMILAR DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF BIOSIMILAR DRUG
8.1 Hospira
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Hospira 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Hospira 2015 Biosimilar Drug Business Region Distribution Analysis
8.2 Sandoz
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Sandoz 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sandoz 2015 Biosimilar Drug Business Region Distribution Analysis
8.3 Teva Pharmaceutical Industries
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Teva Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Teva Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Pfizer 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2015 Biosimilar Drug Business Region Distribution Analysis
8.5 Merck Sharp & Dohme
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck Sharp & Dohme 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck Sharp & Dohme 2015 Biosimilar Drug Business Region Distribution Analysis
8.6 Celltrion
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Celltrion 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celltrion 2015 Biosimilar Drug Business Region Distribution Analysis
8.7 Amgen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Amgen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amgen 2015 Biosimilar Drug Business Region Distribution Analysis
8.8 Biogen
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Biogen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Biogen 2015 Biosimilar Drug Business Region Distribution Analysis
8.9 Mylan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Mylan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Mylan 2015 Biosimilar Drug Business Region Distribution Analysis
8.10 Biocon
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Biocon 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Biocon 2015 Biosimilar Drug Business Region Distribution Analysis
8.11 Dr. Reddy’s Laboratories
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Business Region Distribution Analysis
8.12 Boehringer Ingelheim GmbH
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Business Region Distribution Analysis
8.13 Intas Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Intas Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Intas Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.14 LG Life Sciences
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 LG Life Sciences 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 LG Life Sciences 2015 Biosimilar Drug Business Region Distribution Analysis
8.15 Emcure Pharmaceuticals
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Emcure Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Emcure Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.16 Probiomed
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Probiomed 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Probiomed 2015 Biosimilar Drug Business Region Distribution Analysis
8.17 Biosidus
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Biosidus 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Biosidus 2015 Biosimilar Drug Business Region Distribution Analysis
8.18 3SBio
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 3SBio 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 3SBio 2015 Biosimilar Drug Business Region Distribution Analysis
8.19 WOCKHARDT
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 WOCKHARDT 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 WOCKHARDT 2015 Biosimilar Drug Business Region Distribution Analysis
8.20 Sun Pharmaceutical Industries
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Sun Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Sun Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.21 Shanghai Fosun Pharmaceutical
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.22 Qilu Pharmaceutical
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 Qilu Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 Qilu Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.23 Allergan
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Allergan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Allergan 2015 Biosimilar Drug Business Region Distribution Analysis
8.24 Dongbao
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Dongbao 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Dongbao 2015 Biosimilar Drug Business Region Distribution Analysis
8.25 Samsung Biologics
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.3 Samsung Biologics 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.25.4 Samsung Biologics 2015 Biosimilar Drug Business Region Distribution Analysis
8.26 Zydus Cadila.
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.3 Zydus Cadila. 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.26.4 Zydus Cadila. 2015 Biosimilar Drug Business Region Distribution Analysis
8.27 Dong-A Pharmaceutical
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.3 Dong-A Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.27.4 Dong-A Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
9 DEVELOPMENT TREND OF ANALYSIS OF MARKET
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Biosimilar Drug Consumption Forecast
9.2.2 China 2016-2021 Biosimilar Drug Consumption Forecast
9.2.3 Europe 2016-2021 Biosimilar Drug Consumption Forecast
9.2.4 Japan 2016-2021 Biosimilar Drug Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 BIOSIMILAR DRUG MARKETING MODEL ANALYSIS
10.1 Biosimilar Drug Regional Marketing Model Analysis
10.2 Biosimilar Drug International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Biosimilar Drug by Regions
10.4 Biosimilar Drug Supply Chain Analysis
11 CONSUMERS ANALYSIS OF BIOSIMILAR DRUG
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF BIOSIMILAR DRUG
12.1 New Project SWOT Analysis of Biosimilar Drug
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug
13 CONCLUSION OF THE GLOBAL BIOSIMILAR DRUG MARKET PROFESSIONAL SURVEY REPORT 2016
